A leading investor in Life Sciences

HBM Partners is among the global leaders in healthcare-focused investing with approximately USD 800 million under management. HBM focuses on developmentstage, growth and buy-out financings of private companies as well as investments in public companies. HBM Partners advises HBM BioVentures AG, HBM BioCapital and further specialized private-equity and public-equity funds. HBM has a complementary team of experienced professionals to source, analyze, execute and exit investments in the pharma/biotech, medical devices and diagnostics industries. We have been an active contributor to value creation in our portfolio companies, generating over 40 trade sales and IPOs since inception.